Athira Pharma, Inc. (ATHA) Misses Q1 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Medtronic jumps on earnings beat and raised guidance
• Janus Living (JAN) 7500 contracts of September 35 calls trade
• Duolingo (DUOL) call put ratio 1.5 calls 1 put as share price up 6.2%.